| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | — | — |
| Cost of Revenue | $2.7M | — | — |
| Gross Profit | $1.0M | — | — |
| R&D Expense | $84K | +3792.3% | — |
| SG&A Expense | $19K | -78.2% | -76.8% |
| Operating Income | $574K | +745.3% | +803.5% |
| Net Income | $543K | +678.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $394K | +5.5% | — |
| Accounts Receivable | $1.9M | +93.2% | — |
| Inventory | $1.5M | +19.9% | — |
| Current Assets | $6.3M | +12.6% | — |
| Total Assets | $15.4M | +8.5% | — |
| Current Liabilities | $4.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Investing Cash Flow | $153K | — | — |
| Financing Cash Flow | $579K | — | — |
| +748.8% |
| EPS (Basic) | $0.01 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| +11.9% |
| +944.0% |
| Total Liabilities | $4.5M | +17.0% | +992.3% |
| Stockholders' Equity | $11.0M | +5.3% | +2863.0% |